ALGSNasdaq United States
Market cap
$34.592 M
$5.59 +1.45%
Close of 7 Aug 2026
Revenue
$2.19M
#3421 by revenue
Earnings
-$24.2M
Loss-making
Shares outstanding
6,236,828
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Aligos Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.